#GENF #GenflowBiosciences
Entering the most important 2-3 weeks of it's existence. Their SLAB study met it's Primary endpoint. Full details will be presented at ALOS conference. Commercial Deal Imminent. This will open the way to studies in humans.
drchrisholmes.substack.com/p/genflow-bi...